⌘K

Login Start Free

Home/Filings/4/0001649094-24-000124

4//SEC Filing

Cowan Elvia 4

Accession 0001649094-24-000124

CIK 0001649094other

View on SEC.gov Company Profile

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 4:13 PM ET

Size

7.1 KB

Accession

0001649094-24-000124

Insider Transaction Report

Form 4

Period: 2024-12-16

Vaxcyte, Inc.PCVX

SVP, FINANCE

Transactions

Exercise/Conversion
Common Stock
2024-12-16$25.92/sh+7,716$199,999→ 19,294 total
Exercise/Conversion
Stock Option (right to buy)
2024-12-16−7,716→ 106,284 total
Exercise: $25.92Exp: 2032-08-08→ Common Stock (7,716 underlying)

Footnotes (1)

[F1]1/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.

Documents

1 file

4
wk-form4_1734556392.xmlPrimary
FORM 4

Issuer

Vaxcyte, Inc.

CIK 0001649094

Entity typeother

Related Parties

1

filerCIK 0001960048

Filing Metadata

Form type: 4
Filed: Dec 17, 7:00 PM ET
Accepted: Dec 18, 4:13 PM ET
Size: 7.1 KB

View on SEC.gov